Tachykinin antagonists: substitutions in positions 5 and 6 with amino acids from the primary sequence of substance P homologues
- PMID: 2412854
- DOI: 10.1016/0014-2999(85)90622-3
Tachykinin antagonists: substitutions in positions 5 and 6 with amino acids from the primary sequence of substance P homologues
Abstract
A series of tachykinin antagonists has been synthetized by substituting the amino acids of eight naturally occurring tachykinins into the general antagonist [pro4, trp7,9, Phe 11]tachykinin-(4-11). Five decapeptide antagonists were also synthetized. These antagonists were tested on four smooth muscle preparations, the rabbit mesenteric vein, the guinea-pig ileum, the guinea-pig trachea and the rat urinary bladder. On all tissues, except the rat urinary bladder, antagonists that had amino acids other than Gln5 Gln6 found in the substance P molecule were inactive as antagonists, and some had marked intrinsic activity on the guinea-pig ileum and the guinea-pig trachea. The inhibitory activity of these antagonists on the rat urinary bladder, however, was quite marked. The activities of these antagonists on the rat urinary bladder can be summarized as follows: (a) In general decapeptide antagonists were of low affinity. (b) Octapeptide antagonists showed variable affinities against the various tachykinins and some were selective. The only two antagonists which were fairly active against all tachykinins were [pro4, trp7,9, Phe11]SP-(4-11) and [pro4, trp7,9, Phe11] UPE-(4-11). (c) Physalaemin was frequently antagonized in a non-surmountable manner. (d) Eledoisin and kassinin were each inhibited by only one antagonist, and the antagonist was different for each tachykinin. Some tachykinin receptors on smooth muscle have a binding site which is highly selective for Gln5 Gln6, especially if the affinity of antagonists is considered. Another tissue, the rat urinary bladder, does not exhibit this selectivity.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Tachykinin receptors in smooth muscles: a study with agonists (substance P, neurokinin A) and antagonists.Eur J Pharmacol. 1985 Nov 26;118(1-2):25-36. doi: 10.1016/0014-2999(85)90659-4. Eur J Pharmacol. 1985. PMID: 2417867
-
An examination of the pharmacology of two substance P antagonists and the evidence for tachykinin receptor subtypes.Br J Pharmacol. 1986 Jan;87(1):79-85. doi: 10.1111/j.1476-5381.1986.tb10159.x. Br J Pharmacol. 1986. PMID: 2420403 Free PMC article.
-
A comparison of the effects of three substance P antagonists on tachykinin-stimulated [3H]-acetylcholine release in the guinea-pig ileum.Br J Pharmacol. 1986 Jan;87(1):73-7. doi: 10.1111/j.1476-5381.1986.tb10158.x. Br J Pharmacol. 1986. PMID: 2420402 Free PMC article.
-
Substance P--structure-activity studies and the development of antagonists.Pharmacology. 1984;28(6):301-20. doi: 10.1159/000137979. Pharmacology. 1984. PMID: 6203130 Review.
-
Neurokinin receptor subtypes characterized by biological assays.Life Sci. 1994;54(26):2035-47. doi: 10.1016/0024-3205(94)00712-8. Life Sci. 1994. PMID: 8208061 Review.
Cited by
-
Neuropeptides activate human mast cell degranulation and chemokine production.Immunology. 2008 Mar;123(3):398-410. doi: 10.1111/j.1365-2567.2007.02705.x. Epub 2007 Oct 6. Immunology. 2008. PMID: 17922833 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources